Muscle Spasticity Of Cerebral Origin — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for muscle spasticity of cerebral origin. 18 active patents protecting 1 drugs from 0+ originators. First major cliff: 2037. Daily refresh.

1
Approved drugs
18
Active US patents
62/100
Avg vulnerability
Annual revenue covered

Originators in Muscle Spasticity Of Cerebral Origin

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating muscle spasticity of cerebral origin. Each bar = one year. Y-axis scaled to peak year (10 patents).

2
37
10
39

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Lioresal
BACLOFEN
18 62 2037-09-08

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11850225 Lioresal method of use 75 2041-09-29
11850225 Lioresal method of use 75 2041-09-29
11850225 Lioresal method of use 75 2041-09-29
11446246 Lioresal method of use 70 2037-09-08
11491125 Lioresal method of use 70 2041-09-29
11491125 Lioresal method of use 70 2041-09-29
11491125 Lioresal method of use 70 2041-09-29
10792262 Lioresal method of use 62 2039-07-29
10792262 Lioresal method of use 62 2039-07-29
10792262 Lioresal method of use 62 2039-07-29

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
11654124 Lioresal formulation 50 2039-07-29
11654124 Lioresal formulation 50 2039-07-29
11654124 Lioresal formulation 50 2039-07-29
11324696 Lioresal formulation 50 2037-09-29
11931328 Lioresal formulation 55 2039-07-29
11931328 Lioresal formulation 55 2039-07-29
11931328 Lioresal formulation 55 2039-07-29
10610502 Lioresal method of use 62 2039-08-30
10792262 Lioresal method of use 62 2039-07-29
10792262 Lioresal method of use 62 2039-07-29

Related